PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
11455057-5	2001	The animals were divided in 2 groups of 10 each: (1) intravenous injection of sodium fluorescein (14 mg/kg of body weight)--Group NaF, (2) controls (injection of NaCl 0.9%)--Group CTRL.	Fluorescein	78-96	C-X-C motif chemokine ligand 8	Homo sapiens	130-133	
8256463-5	1993	Fluorescent light intensity is, however, significantly increased, indicating an increased transcapillary diffusion of sodium fluorescein (NaF) as a marker for enhanced leakage of the capillaries in the early stage of the disease.	Fluorescein	118-136	C-X-C motif chemokine ligand 8	Homo sapiens	138-141	
7556959-5	1995	Transcapillary diffusion of sodium fluorescein (NaF) was quantitated by video densitometry in the skin in all subjects on the 4th treatment day.	Fluorescein	28-46	C-X-C motif chemokine ligand 8	Homo sapiens	48-51	
7558620-3	1995	Transcapillary diffusion of intravenously injected sodium fluorescein (NaF) was quantitated by videodensitometry in terms of fluorescent light intensities (FLIs) 5, 10, 20, 30, 60, 120, 180 and 300 s after the first appearance of the dye.	Fluorescein	51-69	C-X-C motif chemokine ligand 8	Homo sapiens	71-74	
10583451-1	1999	BACKGROUND: Capillary leakage of sodium-fluorescein (NaF) in the skin reflects capillary permeability and may be a marker of diabetes-associated microcirculatory abnormalities.	Fluorescein	33-51	C-X-C motif chemokine ligand 8	Homo sapiens	53-56	
10487957-10	1999	IL-8 RNA level correlated with corneal fluorescein staining (rho 0.690, P = 0.001) and conjunctival goblet cell density (rho -0.767, P < 0.001).	Fluorescein	39-50	C-X-C motif chemokine ligand 8	Homo sapiens	0-4	
7738357-4	1995	Binding measurements by flow cytometry at 37 degrees C with fluorescein-labeled N-formyl peptide revealed enhanced total N-formyl peptide binding after pretreatment of neutrophils with IL-8 and GRO alpha.	Fluorescein	60-71	C-X-C motif chemokine ligand 8	Homo sapiens	185-189	
7851404-6	1995	The 72-residue interleukin-8 sequence starts with a serine residue, which can be oxidised under mild conditions to give a reactive glyoxylyl function which is then reacted with a nucleophilic fluorescein derivative.	Fluorescein	192-203	C-X-C motif chemokine ligand 8	Homo sapiens	15-28	
1281615-4	1992	Repeat fluorescein angiograms 6 weeks after placing angiogenic doses of rIL-8 demonstrated significant regression (P = 0.01) of the vascularity present at 2 weeks, suggesting that IL-8 angiogenesis undergoes dynamic modulation similar to that normally seen in wound healing.	Fluorescein	7-18	C-X-C motif chemokine ligand 8	Homo sapiens	73-77	
34398388-4	2021	BBB integrity and function were assessed via transendothelial electrical resistance (TEER) and paracellular flux of sodium fluorescein (NaF, 376 Da).	Fluorescein	116-134	C-X-C motif chemokine ligand 8	Homo sapiens	136-139	
35599022-6	2022	Microvessels exhibited physiological relevant trans-endothelial electrical resistance (TEER), were leak-tight for 10 kDa dextran-Alexa 647 and strongly limited the permeability of sodium fluorescein (NaF).	Fluorescein	180-198	C-X-C motif chemokine ligand 8	Homo sapiens	200-203	
35179812-4	2022	The function and integrity of BBB were assessed by measurements of paracellular flux of sodium fluorescein (NaF) and transendothelial electrical resistance (TEER), respectively.	Fluorescein	88-106	C-X-C motif chemokine ligand 8	Homo sapiens	108-111	
2933233-2	1985	Fluorescein flowmetry implies the measurement of capillary blood flow, expressed as an index between the maximum fluorescence after the first circulatory passage of sodium fluorescein (NaF) and the rise time, defined as the time interval between ten and 90 percent of the maximum fluorescence.	Fluorescein	0-11	C-X-C motif chemokine ligand 8	Homo sapiens	185-188	
2933233-2	1985	Fluorescein flowmetry implies the measurement of capillary blood flow, expressed as an index between the maximum fluorescence after the first circulatory passage of sodium fluorescein (NaF) and the rise time, defined as the time interval between ten and 90 percent of the maximum fluorescence.	Fluorescein	165-183	C-X-C motif chemokine ligand 8	Homo sapiens	185-188	
4092416-1	1985	In sixteen patients subjected to intestinal surgery, the transport of sodium fluorescein (Na-F) was measured between the mucosal and serosal-muscular layers.	Fluorescein	70-88	C-X-C motif chemokine ligand 8	Homo sapiens	90-94	
33600064-8	2021	The study demonstrated the ultrasound-triggered release of sodium fluorescein (NaF), bovine serum albumin (BSA), and bone morphogenetic protein 2 (BMP-2) from the hydrogels.	Fluorescein	59-77	C-X-C motif chemokine ligand 8	Homo sapiens	79-82	
4006409-1	1985	The present work represents an attempt to develop a method for measuring relative blood flow in intestinal capillaries, by the use of sodium fluorescein (Na-F) as an indicator substance.	Fluorescein	134-152	C-X-C motif chemokine ligand 8	Homo sapiens	154-158	
31954196-6	2020	Furthermore, the levels of IL-6 and IL-8 showed a stronger correlation with corneal fluorescein staining (CFS) (P<0.05), and the levels of IL-6 and ICAM-1 were most consistent with fluorescein tear film break-up time (TBUT) (P<0.05).	Fluorescein	84-95	C-X-C motif chemokine ligand 8	Homo sapiens	36-40	
19046206-1	2008	AIMS: To measure capillary permeability, assessed by skin capillary sodium fluorescein (NaF) leakage, in patients with diabetes mellitus with critical limb ischaemia (DM-CLI) and to compare the effects of vascular endothelial growth factor (VEGF) with those of placebo.	Fluorescein	68-86	C-X-C motif chemokine ligand 8	Homo sapiens	88-91	
29193173-4	2018	Further, LSCM can image sodium fluorescein (NaF) fluorescence with 488 nm excitation (fluorescence confocal microcopy (FCM)), a small hydrophilic test molecule (370 MW, log P -1.52), which may simulate uptake, bio-distribution and kinetics of small hydrophilic drugs.	Fluorescein	24-42	C-X-C motif chemokine ligand 8	Homo sapiens	44-47	
23430672-11	2013	In the DEDG, significant negative correlations were detected between the Schirmer test and IL-1beta, IL6, IL8, and vascular endothelial growth factor levels, and between the fluorescein breakup time with IL6 and IL8 levels.	Fluorescein	174-185	C-X-C motif chemokine ligand 8	Homo sapiens	212-215	
17922819-11	2007	At 72 h the trilayer severely restricted transfer of sodium fluorescein (NaF) (ten-fold reduction) whilst transfer of a 4 kDa FITC-conjugated dextran was virtually occluded, confirming a restrictive barrier.	Fluorescein	53-71	C-X-C motif chemokine ligand 8	Homo sapiens	73-76